Discovery of a highly potent, selective, orally bioavailable inhibitor of KAT6A/B histone acetyltransferases with efficacy against KAT6A-high ER+ breast cancerShikhar Sharma, Meghan Hattarki, Anthony Mazurek et al.|Cell chemical biology|2023Cited by 72
Catalytic Inhibition of KAT6/KAT7 Enhances the Efficacy and Overcomes Primary and Acquired Resistance to Menin Inhibitors in MLL LeukemiaShellaina J.V. Gordon, Mark A. Dawson, Florian Perner et al.|Cancer Discovery|2025Cited by 20
Catalytic inhibition of KAT6/KAT7 enhances the efficacy and overcomes primary and acquired resistance to Menin inhibitors in MLL leukaemiaShellaina J.V. Gordon, Mark A. Dawson, Florian Perner et al.|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 5
Data from Catalytic Inhibition of KAT6/KAT7 Enhances the Efficacy and Overcomes Primary and Acquired Resistance to Menin Inhibitors in MLL LeukemiaShellaina J.V. Gordon, Mark A. Dawson, Florian Perner et al.|Unknown|2025Cited by 0
Supplementary Tables S1-14 from Catalytic Inhibition of KAT6/KAT7 Enhances the Efficacy and Overcomes Primary and Acquired Resistance to Menin Inhibitors in MLL LeukemiaShellaina J.V. Gordon, Mark A. Dawson, Florian Perner et al.|Unknown|2025Cited by 0